Literature DB >> 11040432

Effect of enterocin CRL35 on Listeria monocytogenes cell membrane.

C J Minahk1, M E Farías, F Sesma, R D Morero.   

Abstract

The antimicrobial peptide Enterocin CRL35, a class II bacteriocin, produces at high concentrations (8 microg ml(-1)) localized holes in the wall and cellular membrane of Listeria monocytogenes, reflected in the efflux of macromolecules such as proteins and other ultraviolet-absorbing materials. At lower concentrations (0.5 microg ml(-1)), neither ultra structural changes nor macromolecules efflux were observed, however potassium and phosphate ions were released, dissipating the proton motive force. As a result the bacteria were killed.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11040432     DOI： 10.1111/j.1574-6968.2000.tb09362.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN： 0378-1097            Impact factor:   2.742


  9 in total

Review 1.  Pediocin-like bacteriocins: new perspectives on mechanism of action and immunity.

Authors:  Natalia S Ríos Colombo; Miriam C Chalón; Silvia A Navarro; Augusto Bellomio
Journal:  Curr Genet       Date:  2017-10-05       Impact factor: 3.886

2.  Characterization of a bacteriocin produced by Lactococcus lactis subsp. lactis CRL 1584 isolated from a Lithobates catesbeianus hatchery.

Authors:  Sergio E Pasteris; Esteban Vera Pingitore; Cesar E Ale; María E Fatima Nader-Macías
Journal:  World J Microbiol Biotechnol       Date:  2013-10-23       Impact factor: 3.312

3.  Bactericidal activity of glycinecin A, a bacteriocin derived from Xanthomonas campestris pv. glycines, on phytopathogenic Xanthomonas campestris pv. vesicatoria cells.

Authors:  Huy Thang Pham; Key Zoung Riu; Kong Man Jang; Somi K Cho; Moonjae Cho
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

4.  A new hybrid bacteriocin, Ent35-MccV, displays antimicrobial activity against pathogenic Gram-positive and Gram-negative bacteria.

Authors:  Leonardo Acuña; Gianluca Picariello; Fernando Sesma; Roberto D Morero; Augusto Bellomio
Journal:  FEBS Open Bio       Date:  2012-01-31       Impact factor: 2.693

5.  Novel enterocin E20c purified from Enterococcus hirae 20c synergised with ß-lactams and ciprofloxacin against Salmonella enterica.

Authors:  Preeti Sharma; Muzamil Rashid; Sukhraj Kaur
Journal:  Microb Cell Fact       Date:  2020-05-04       Impact factor: 5.328

Review 6.  Bacteriocins: Potential for Human Health.

Authors:  Fuqing Huang; Kunling Teng; Yayong Liu; Yanhong Cao; Tianwei Wang; Cui Ma; Jie Zhang; Jin Zhong
Journal:  Oxid Med Cell Longev       Date:  2021-04-10       Impact factor: 6.543

7.  In Vitro and In Silico Based Approaches to Identify Potential Novel Bacteriocins from the Athlete Gut Microbiome of an Elite Athlete Cohort.

Authors:  Laura Wosinska; Calum J Walsh; Paula M O'Connor; Elaine M Lawton; Paul D Cotter; Caitriona M Guinane; Orla O'Sullivan
Journal:  Microorganisms       Date:  2022-03-24

8.  The bacteriocin Angicin interferes with bacterial membrane integrity through interaction with the mannose phosphotransferase system.

Authors:  Verena Vogel; Lia-Raluca Olari; Marie Jachmann; Sebastian J Reich; Michelle Häring; Ann-Kathrin Kissmann; Frank Rosenau; Christian U Riedel; Jan Münch; Barbara Spellerberg
Journal:  Front Microbiol       Date:  2022-09-06       Impact factor: 6.064

9.  BacSJ-Another Bacteriocin with Distinct Spectrum of Activity that Targets Man-PTS.

Authors:  Aleksandra Tymoszewska; Piotr Walczak; Tamara Aleksandrzak-Piekarczyk
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.